IFITM1 and glioma: A similar contradiction has been described in glioma cells where knockdown of IFITM1 was demonstrated to inhibit proliferation, migration and invasion [17, 18], whereas reduced expression of IFITM1 correlated with shorter survival in a cohort of 30 glioma patients [17].